About Us
News
Products
Technolongy Platform
Investors
Contact Us
中文
EN
NEWS
Business Milestones
Patents
ALL
無列表圖
Business Milestones
03.17
2026
TAHO Pharmaceuticals Announces Grant of Korean Patent for BEQIA
無列表圖
Business Milestones
02.03
2026
TAHO Pharmaceuticals to Present Scientific Abstract at APSC Congress 2026
無列表圖
Patents
01.26
2026
TAHO Pharmaceuticals Receives Taiwan Patent Allowance for TAH2231, A Naloxone Buccal Film for Opioid Overdose Rescue
無列表圖
Business Milestones
11.27
2025
TAHO Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application for BEQIA(TAH3311), the world’s first Apixaban Oral Dissolving Film (ODF)
無列表圖
Business Milestones
10.31
2025
TAHO Pharmaceuticals Submits First Application to the European Medicines Agency for TAH3311, the World’s First Apixaban Orodispersible Film
無列表圖
Business Milestones
10.01
2025
TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 – The World’s First Apixaban Oral Dissolving Film – Represents a Transformational Advancement in Anticoagulant Therapy
無列表圖
Business Milestones
06.16
2025
TAHO Pharmaceuticals Secures Two Taiwan Patents for TAH3311 Apixaban Anticoagulant Oral Dissolving Film
無列表圖
Business Milestones
06.13
2025
TAHO Pharmaceuticals to Showcase Cardiovascular Innovations at BIO International Convention 2025
無列表圖
Business Milestones
06.11
2025
TAHO Pharmaceuticals Receives Patent Acceptance for TAH3311 Apixaban Oral Dissolving Film in South Africa
無列表圖
Business Milestones
05.19
2025
TAHO Pharmaceuticals Secures Singapore Patent for TAH3311 Apixaban Anticoagulant Oral Dissolving Film
1
2
3
Next Page
Last Page
中文
EN
About Us
News
Products
Technolongy Platform
Investors
Contact Us
ADD
3F., No. 550, Ruiguang Road, Neihu District, Taipei, 11492, Taiwan
TEL
+886-2-2659-8515
MAIL
[email protected]
© 2023 TAHO Pharmaceuticals Ltd. All rights reserved.
Design ibest
Verification
Click the numbers in sequence.
Change
